5[5]Onder I.Topcu S,Dokmetas HS,et al.Platelet aggregation size and volume in chronic obstructive pulmonary disease.Mater Med Pol,1997,29:11-13.
6[6]Dahl M,Tybjaerg-Hansen A,Vestbo J,et al.Elavated plasma fibrinogen associated with reduced pulmonary function and increased risk of chronic obstructive pulmonary disease.Am J Respir Crit Care Med,2001,164(6):1008-1011.
3Ashitani J, Mukae H, Arimura Y, et al. Elevated plasmap rocoagulant and fibrinolytic markers in patients with chronic obstructive pulmonary disease[J]. Intern Med, 2002,41 (3)181.
4CooK N S, Ubben D. Fibrinogcn as a major risk in cardiovascular disease [J]. Trends Pharmacol Sci, 1990,11 (4) : 444.
5Ernst E. Fibrinogen: an important risk factor for atherothrombotic diseases [J]. Ann Med, 1994, 26 (1) : 15.
6Danl M, Tybjaerg Hansen A, Vestbo J, et al. Elevated plasma fibrinogen associated with reduced pulmonary function and increased risk of chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med, 2001, 15,164(6):1008.
7Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation[J]. N Engl J Med, 1999,340(4):448.
8Cordova C, Violi F, Alessandri C, et al. Improvement of blood gas levels after calciumheparin treatment in patients with chronic obstructive pulmonary disease [J]. Thromb Res, 1992,68 (3)435.
